PSA delisting advice
November 4, 2015
The Pharmaceutical Society of
Australia has issued information for
consumers in the light of the PBS
delisting of 17 types of medicines
effective 01 Jan (PD Mon).
PSA president Joe Demarte said
people who normally access these
medications - such as paracetamol
and aspirin - via a PBS prescription
will now need to discuss the change
with their pharmacist and be well
prepared before it is effective.
“Pharmacists know from previous
experience that significant changes
to PBS rules can create a number of
problems for patients and carers.
“We are concerned about the
financial impact in accessing some
of these medicines, as they may
end up costing patients more due
to the delisting,” he said, with
consumers set to reach the Safety
Net later due to the change.
MEANWH ILE GlaxoSmithKline
director Healthcare Environment,
David Herd, has confirmed that
Panadol Osteo will no longer be
reimbursed, saying the 01 Jan 2016
timeframe is “challenging”.
He said GSK will work with health
professionals to “ensure consumers
can continue to receive Panadol
Osteo as a first line treatment for
their osteoarthritis pain”.
The above article was sent to subscribers in Pharmacy Daily's issue from 04 Nov 15To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 04 Nov 15
